bioAffinity Technologies (BIAF) Cash from Investing Activities (2023 - 2025)
bioAffinity Technologies (BIAF) has disclosed Cash from Investing Activities for 3 consecutive years, with -$1.0 as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities changed 0.0% to -$1.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60568.0 through Dec 2025, up 23.41% year-over-year, with the annual reading at -$60568.0 for FY2025, 23.41% up from the prior year.
- Cash from Investing Activities for Q4 2025 was -$1.0 at bioAffinity Technologies, down from $3646.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $13442.0 in Q4 2023, with the low at -$2.2 million in Q3 2023.
- Average Cash from Investing Activities over 3 years is -$195754.2, with a median of -$11418.5 recorded in 2024.
- The sharpest move saw Cash from Investing Activities plummeted 632.58% in 2024, then soared 138.75% in 2025.
- Over 3 years, Cash from Investing Activities stood at $13442.0 in 2023, then crashed by 100.01% to -$1.0 in 2024, then changed by 0.0% to -$1.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1.0, $3646.0, and -$13427.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.